BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12721279)

  • 1. Acute hypokalemic tetraparesis induced by intravenous methotrexate.
    Thuss-Patience PC; Peters U; Jurkat-Rott K; Pink D; Kretzschmar A; Dörken B; Reichardt P
    J Clin Oncol; 2003 May; 21(9):1896-7. PubMed ID: 12721279
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
    Mahadeo KM; Santizo R; Baker L; Curry JO; Gorlick R; Levy AS
    Pediatr Blood Cancer; 2010 Dec; 55(7):1296-9. PubMed ID: 20949591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature.
    Perez-Verdia A; Angulo F; Hardwicke FL; Nugent KM
    Pharmacotherapy; 2005 Sep; 25(9):1271-6. PubMed ID: 16164401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
    Womer RB
    Pediatr Blood Cancer; 2010 Dec; 55(7):1250-1. PubMed ID: 20981687
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose methotrexate-induced bullous variant of acral erythema.
    Hellier I; Bessis D; Sotto A; Margueritte G; Guilhou JJ
    Arch Dermatol; 1996 May; 132(5):590-1. PubMed ID: 8624164
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective removal of methotrexate by high-flux hemodialysis.
    Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
    Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
    Tuffaha HW; Al Omar S
    J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-dose methotrexate and cerebral neurotoxicity. Apropos of a case of arachnoiditis].
    Brain E; Alexandre J; Minozzi C; Misset JL
    Presse Med; 1997 Mar; 26(6):265-8. PubMed ID: 9122123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE; Chaffee S; Dinulos JG
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemiparesis in acute lymphoblastic leukemia].
    Karremann M; von Komorowski G; Neumaier-Probst E; Dürken M
    Radiologe; 2010 Aug; 50(8):706-10. PubMed ID: 20652214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-induced periorbital radiation recall.
    Kiel PJ; Jones KL
    Ann Pharmacother; 2011 Jan; 45(1):133. PubMed ID: 21205951
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
    Yamada K; Takahashi M; Yoshida M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate is lethal to rats. Why give it to children?
    Cole PD; Kamen BA
    Pediatr Hematol Oncol; 2000 Dec; 17(8):609-13. PubMed ID: 11127392
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
    Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
    J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated achilles tendinitis after high dose methotrexate.
    Toverud EL; Landaas S; Hellebostad M
    Med Pediatr Oncol; 2001 Aug; 37(2):156. PubMed ID: 11496361
    [No Abstract]   [Full Text] [Related]  

  • 17. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly oral methotrexate therapy: raise awareness of fatal dosing errors.
    Prescrire Int; 2013 May; 22(138):126. PubMed ID: 23819175
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia.
    Lau KK; Weiss AR; Jones DP
    J Oncol Pharm Pract; 2005 Mar; 11(1):31-3. PubMed ID: 16460601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.